DA-1726 IND Application Submitted to FDA for Phase 1 Clinical Trial in Obesity Treatment Obesity has become a global epidemic,...
A Guide to Managing Phase 1 Clinical Studies in BioPharma Services Phase 1 clinical studies play a crucial role in...
Everest Medicines, a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products for patients in Greater China and other...
Zetomipzomib’s Investigational New Drug Application Accepted in China, Announces Everest Medicines Everest Medicines, a biopharmaceutical company focused on developing and...
The Food and Drug Administration (FDA) has recently cleared the Phase 1B Investigational New Drug (IND) application for TCB-008, a...
Updates on Stem Cells for Multiple Sclerosis, Kimera Labs IND, and FDA Lawsuit: A Weekly Recap In the field of...